Biotech

Biotech The latest news and information in the Biotechnology industry. Follow us to stay up to date on ever

New Gene-Editing Tool Could Rival CRISPR 🧬🔬🧫A new tool uses segments of bacterial DNA to perform millions of genetic exp...
05/12/2021

New Gene-Editing Tool Could Rival CRISPR 🧬🔬🧫

A new tool uses segments of bacterial DNA to perform millions of genetic experiments simultaneously. These segments are known as retrons and used to produce fragments of single-stranded DNA. Created by Researchers from the Harvard’s Wyss Institute for Biologically Inspired Engineering (), called the (Retron Library Recombineering) RLR technique.
——
CRISPR-Cas9 is the primary technique in gene-editing, gives researchers the tools needed to alter DNA sequences. While this technique has a variety of potential applications, including life-saving treatments for various illnesses, CRISPR has its limitations. The Cas9 enzyme, known as “molecular scissors”, which slices segments of DNA, often cuts non-targeted sites and can be toxic to cells. CRISPR-Cas9 are not easily delivered in large quantities, limiting studies and increases experiment time.
——
The newly introduced RLR technique proved to be successful in large-scale genetic experiments. Harvard researchers tested RLR on E. coli bacteria to locate antibiotic resistance mutations. Researchers explained how they were able to randomly chop up a bacterial genome, turn genetic fragments into single-stranded DNA in situ and use them to screen millions of sequences simultaneously. By sequencing retron barcodes instead of individually, making the process a lot faster.
——
Do you support gene editing in humans or are you against it?

❤️ Like 💬 Comment 📤 Share

🔗 Full Article Link in Bio
🆔

✍️ Eduardo Cortez ()

📰 Engadget ()
🔸 Mariella Moon (May 2021) “Harvard scientists create gene-editing tool that could rival CRISPR”

# biologist

Gene therapy for Duchenne muscular dystrophy: nearing final tests 💪🧬🧪By next year, two companies could have gene therapi...
04/27/2021

Gene therapy for Duchenne muscular dystrophy: nearing final tests 💪🧬🧪

By next year, two companies could have gene therapies for Duchenne muscular dystrophy in late-stage clinical trials. The start of those studies will mark the culmination of years of research, a milestone that could finally put a gene therapy for the debilitating disease within reach.

Both treatments, along with a third a little further behind, hold the potential to change Duchenne's course, driving excitement and hope of a potential breakthrough for patients, most of whom don't have good treatment options.

Three companies — Sarepta, Pfizer and Solid Biosciences — have similar Duchenne gene therapies in human testing.

Share this good news!

🔗 Full Article Link in Bio
🆔

✍️ Astrobiotechnology ()
🖼️ Astrobiotechnology ()

📰 Source: BioPharma Dive

Natural Biohack for better health: love ❤️🩺🧬Researches at Harvard Medical School () did a survey of 127,545 American adu...
04/26/2021

Natural Biohack for better health: love ❤️🩺🧬

Researches at Harvard Medical School () did a survey of 127,545 American adults found that married men are healthier than men who were never married or whose marriages ended in divorce or widowhood.

They learned that married man:
👴 Live longer
❤️ Less likely to have coronary diseases
🧠 Reduced risk of Alzheimer's
🩸Improved blood sugar levels
🩺Better outcomes for hospitalized patients

Are you ready to sai "I do" ?

❤️ Like 💬 Comment 📤 Share

🔗 Full Article Link in Bio
🆔

✍️ Astro Biotechnology ()
🖼️ Harvard Medical School ()

📰 Source: Harvard Medical School ()
🔸 Harvard Health, “Marriage and men's health”

FDA, CDC support resuming use of J&J vaccine after advisory panel vote 🦠💉🧪A group of advisers to the Centers for Disease...
04/26/2021

FDA, CDC support resuming use of J&J vaccine after advisory panel vote 🦠💉🧪

A group of advisers to the Centers for Disease Control and Prevention said vaccinations with Johnson & Johnson's coronavirus shot should be resumed in the U.S., deciding in a Friday meeting that updated labeling would be sufficient to alert healthcare providers and the public to the risk of a rare but serious side effect.

The advisers voted 10-4 in favor of the recommendation, clearing the way for the CDC and Food and Drug Administration to lift their recommended pause on vaccinations just two hours later.

Would you take the J&J shot?

❤️ Like 💬 Comment 📤 Share

🔗 Full Article Link in Bio
🆔

📰 Source: CDC ()

DNA robots designed in minutes instead of days 🧬🤖⌛Researchers took a big step toward that future by developing a new too...
04/26/2021

DNA robots designed in minutes instead of days 🧬🤖⌛

Researchers took a big step toward that future by developing a new tool that can design much more complex DNA robots and nanodevices than were ever possible before in a fraction of the time.

The software helps researchers design ways to take tiny strands of DNA and combine them into complex structures with parts like rotors and hinges that can move and complete a variety of tasks, including drug delivery.

Can you foresee the use for this kind of experiment?

❤️ Like 💬 Comment 📤 Share

🔗 Full Article Link in Bio
🆔

📰 Source: Science Daitly
🔸Huang (April, 2021), “Integrated computer-aided engineering and design for DNA assemblies”

First monkey–human embryos reignite debate over hybrid animals 🐒🧪👶Scientists have successfully grown monkey embryos cont...
04/23/2021

First monkey–human embryos reignite debate over hybrid animals 🐒🧪👶

Scientists have successfully grown monkey embryos containing human cells for the first time — the latest milestone in a rapidly advancing field that has drawn ethical questions.

In the work, published on 15 April in Cell () the team injected monkey embryos with human stem cells and watched them develop. They observed human and monkey cells divide and grow together in a dish, with at least 3 embryos surviving to 19 days after fertilization. “The overall message is that every embryo contained human cells that proliferate and differentiate to a different extent,” says Juan Carlos Izpisua Belmonte, a developmental biologist at the Salk Institute for Biological Studies in La Jolla, California, and one of the researchers who led the work.

Researchers hope that some human–animal hybrids — known as chimaeras — could provide better models in which to test drugs, and be used to grow human organs for transplants. Members of this research team were the first to show in 20192 that they could grow monkey embryos in a dish for up to 20 days after fertilization. In 2017, they reported a series of other hybrids: pig embryos grown with human cells, cow embryos grown with human cells, and rat embryos grown with mouse cells.

What do you think about hybrid animals?

❤️ Like 💬 Comment 📤 Share

🔗 Full Article Link in Bio
🆔

✍️ Astrobiotechnology ()
🖼️ NPR ()

🗃️ Source: Cell ()
🔸 Tan et al (April, 2021) , “Chimeric contribution of human extended pluripotent stem cells to monkey embryos ex vivo”

04/23/2021

Tardive Dyskinesia 🧠⚡😐

Tardive dyskinesia (TD) is a movement disorder characterized by uncontrolled facial movements, such as repetitive tongue movements, chewing or sucking motions, and involuntarily making faces.

Sequence offering insight into the science of tardive dyskinesia, a neurological syndrome caused by the long-term use of neuroleptic drugs.

When dopamine receptors are blocked, new hypersensitive dopamine receptors rise up from the postsynaptic membrane. As a result, the once-rejected dopamine binds to these new receptors and leads to excessive signaling -- which impacts motor areas of the brain and causes repetitive, involuntary movements.

❤️ Like 💬 Comment 📤 Share
🔗 Full Article Link in Bio
🆔

✍️ Astrobiotechnology ()
🖼️ Hybrid Medical ()

📰 Very Well Mind Cell ()
🔸 Purse et al (September, 20191) , “Myelin Loss Is a Major Factor in Age-Related Brain Deterioration”

NIH awards grants to support bacteriophage therapy research🦵💉💦NIH's National Institute of Allergy and Infectious Disease...
04/22/2021

NIH awards grants to support bacteriophage therapy research🦵💉💦

NIH's National Institute of Allergy and Infectious Diseases (), awarded $2.5 million in grants to 12 institutes around the world to support research on bacteriophage therapy, an emerging field that could yield new ways to fight antimicrobial-resistant bacteria.

A 2019 report from CDC found that antibiotic-resistant pathogens cause more than 2.8 million infections in the U.S. each year and more than 35,000 people die. Bacteriophages (or "phages") are viruses that can kill or incapacitate specific kinds of bacteria while leaving other bacteria and human cells unharmed.

The recipients of the awards are as follows:

🎓 University of Pittsburgh ()

🔍 PhagePro, Inc. (Boston)

🎓 University of Connecticut ()

🎓 Georgia Institute of Technology ()

🎓 University of Wisconsin-Madison ()

🎓 Texas A&M Agrilife Research ()

🎓 Queens College, City University of New York ()

🎓 Harvard School of Public Health ()

🔍 Guild Associates, Inc.

🔍 Geneva Foundation ()

🎓 University of Alabama at Birmingham ()

🎓 Albert Einstein College of Medicine ()

What do you think about “Phage” therapies ?

❤️ Like 💬 Comment 📤 Share
🔗 Full Article Link in Bio
🆔

✍️ Astro Biotechnology ()
🖼️ Farid Ghanbari ()

📰 National Institutes of Health ()

04/21/2021

New Hyaluronic Acid Therapy Presents Chemical and Mechanical Cues Healing Injured Joint Cartilage 🦵💉💦

A new study reports the development of a hyaluronic acid hydrogel system designed to interlock with the affected articular cartilage like fingers in clasped hands. This securely seals the opposing surface of the affected cartilage.
The interdigitating reinforcement restores tissue mass in and around the affected area and re-establishes mechanical signals similar to cartilage cells (chondrocytes) in the original tissue.
The team combined the hyaluronic acid hydrogel system with an injection of mesenchymal stem cells and stromal cells, to promote the formation of a living barrier on the cartilage surface to protect it from further injury. Comparing models that received the treatment to ones that did not, the researchers found that treated models formed a thicker layer of protective tissue that could protect the cartilage’s structure and preserve function.

Do you know anyone that could benefit from this research? Tag them on this good news!

❤️ Like 💬 Comment 📤 Share

🔗 Full Article Link in Bio
🆔

✍️ Astrobiotechnology ()
🖼️ Astrobiotechnology ()

📰 Source: Genetic Engineering & Biotechnology News
🔸 Patel et al (April, 2021), “Stabilization of Damaged Articular Cartilage with Hydrogel‐Mediated Reinforcement and Sealing”

Myelin Loss Shown To Play A Significant Role in Age-Related Brain Deterioration 🧠💊🧬 A team of scientists at the Universi...
04/16/2021

Myelin Loss Shown To Play A Significant Role in Age-Related Brain Deterioration 🧠💊🧬

A team of scientists at the University of Portsmouth has identified myelin loss to be one of the significant factors of age-related brain deterioration.

The study, published in Aging Cell, shows that there is increasing evidence that myelin disruption is an important factor that contributes to the age-related loss of brain plasticity and repair responses. The loss of myelin is shown to be the cause of cognitive decline and is central to several neurodegenerative diseases, such as Multiple Sclerosis and Alzheimer’s disease.

The study found that the cells which are responsible for replenishing lost myelin, become less efficient with age and identified a key gene that is most affected by aging, which in turn reduces the cells' ability to restore lost myelin.

❤️ Like 💬 Comment 📤 Share

🔗 Full Article Link in Bio
🆔

✍️ Siddhant Kamat(
🖼️ Image Source ()

📰 Source: Website/Publication ()
🔸 Rivera et. al (March, 2021) , “Article Title” by Journalist ()

-19

🎓 Siddhant Kamat is a biotechnology graduate from the University of Mumbai and a member of our Internship Program.
📬 Email your resume to [email protected] to apply.

04/16/2021

The Biotech Show 🧬🧪🔬

We are very excited to introduce you to The Biotech Show - International edition.

We will showcase industry trends, interesting research and biotech news coming from speakers all over the world.

Let us know what you would like to know more!

❤️ Like 💬 Comment 📤 Share

04/15/2021

A new handheld 3D printer can deposit sheets of skin to cover large burn wounds – and its “bio ink” can accelerate the healing process 🖨️🤕🔥

The device, developed by a team of researchers from U of T Engineering and Sunnybrook Health Sciences Centre, covers wounds with a uniform sheet of biomaterial, stripe by stripe. The bio ink dispensed by the roller is composed of mesenchymal stroma cells (MSCs) — stem cells that differentiate into specialized cell types depending on their environment. In this case, the MSC material promotes skin regeneration and reduces scarring.

The project is led by Richard Cheng (IBBME PhD candidate), under the supervision of Professor Axel Guenther (MIE), and in close collaboration with Dr. Marc Jeschke, director of the Ross Tilley Burn Centre, and his team at Sunnybrook Hospital. Their successful in-vivo trials on full-thickness wounds are reported in the journal Biofabrication.

The paper is a major step forward for the team, which unveiled the first prototype of the skin printer in 2018. The device was believed to be the first device of its kind to form tissue in situ, depositing and setting in place in two minutes or less.

Do you think 3D printers are the future of biotissues?

❤️ Like 💬 Comment 📤 Share

🔗 Full Article Link in Bio
🆔

✍️ The happy Broadcast ()
🖼️ University of Toronto ()

📰 Source: University of Toronto Engineering news ()
🔸 Publication, “Handheld instrument for wound-conformal delivery of skin precursor sheets improves healing in full-thickness burns ” by Journalist

Address

Cambridge, MA
02115

Alerts

Be the first to know and let us send you an email when Biotech posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Biotech:

Featured

Share